| 000 | 01746 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514222212.0 | ||
| 264 | 0 | _c20050826 | |
| 008 | 200508s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 024 | 7 |
_a10.1124/jpet.105.083139 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAkerman, S | |
| 245 | 0 | 0 |
_aThe role of dopamine in a model of trigeminovascular nociception. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cJul 2005 |
||
| 300 |
_a162-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdrenergic alpha-2 Receptor Antagonists |
| 650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aBlood Vessels _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopamine _xphysiology |
| 650 | 0 | 4 |
_aDopamine Agonists _xpharmacology |
| 650 | 0 | 4 |
_aDopamine Antagonists _xpharmacology |
| 650 | 0 | 4 | _aDopamine D2 Receptor Antagonists |
| 650 | 0 | 4 | _aElectric Stimulation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMigraine Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aPain _xdrug therapy |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Dopamine D1 _xagonists |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xagonists |
| 650 | 0 | 4 | _aReceptors, Dopamine D3 |
| 650 | 0 | 4 | _aReceptors, Dopamine D4 |
| 650 | 0 | 4 |
_aTrigeminal Nerve _xphysiopathology |
| 650 | 0 | 4 |
_aVasodilation _xdrug effects |
| 700 | 1 | _aGoadsby, P J | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 314 _gno. 1 _gp. 162-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/jpet.105.083139 _zAvailable from publisher's website |
| 999 |
_c15450244 _d15450244 |
||